Seoul Pharma Co. Ltd Cash Flow Quality Index
Seoul Pharma Co. Ltd cash flow quality index. Seoul Pharma Co. Ltd (018680) has a Cash Flow Quality Index of -1.01x as of September 2025. Operating cash flow of ₩-2.66 Billion is below net income of ₩2.62 Billion, suggesting accrual-heavy earnings not yet converted to cash. See Seoul Pharma Co. Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Seoul Pharma Co. Ltd (2008–2024)
Cash flow quality index of Seoul Pharma Co. Ltd from 2008 to 2024. Historical Cash Flow Quality Index for Seoul Pharma Co. Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 018680 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Seoul Pharma Co. Ltd Cash Flow Quality Index by Year (2008–2024)
Seoul Pharma Co. Ltd cash flow quality index by year from 2008 to 2024. Year-by-year earnings quality comparison for Seoul Pharma Co. Ltd. For the full cash flow conversion analysis, see 018680 cash generation efficiency.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1.77x | ₩-3.01 Billion | ₩1.70 Billion | ▼ -218.3% |
| 2023 | 1.50x | ₩5.26 Billion | ₩3.52 Billion | ▲ +1736.4% |
| 2022 | -0.09x | ₩-78.21 Million | ₩855.09 Million | ▼ -100.7% |
| 2019 | 12.40x | ₩2.93 Billion | ₩236.21 Million | ▲ +1060.9% |
| 2017 | -1.29x | ₩-1.14 Billion | ₩881.45 Million | ▲ +44.2% |
| 2016 | -2.31x | ₩-1.89 Billion | ₩816.80 Million | ▼ -236.5% |
| 2013 | -0.69x | ₩-425.00 Million | ₩618.00 Million | ▼ -138.1% |
| 2012 | 1.81x | ₩9.22 Billion | ₩5.10 Billion | ▼ -50.4% |
| 2011 | 3.64x | ₩4.86 Billion | ₩1.33 Billion | ▲ +248.5% |
| 2009 | 1.05x | ₩1.23 Billion | ₩1.18 Billion | ▲ +175.0% |
| 2008 | -1.39x | ₩-755.68 Million | ₩542.04 Million | — |